Merck drops depression drug

November 14, 2003

US pharma company Merck has stopped development of a new depression drug in late-stage clinical trials, casting doubt over the …

US healthcare ‘in danger of collapse’

November 13, 2003

The US healthcare system is in "imminent danger of collapse" and needs radical reform, according to one of the country's …

Slimmed down Bayer rules out merger

November 12, 2003

Bayer has unveiled a radical reorganisation of its business, including a refocused pharmaceutical division, but ruled out looking for a …

GlaxoSmithKline to open biotech research centre

November 12, 2003

GlaxoSmithKline is to create a new drug discovery group focused on biopharmaceuticals to capitalise on the potential of its large …

‘European FDA’ one step closer

November 6, 2003

Europe looks set to emulate US medicines regulator the FDA by transferring responsibility from national agencies to a single centralised …

Lords reject ‘shambolic’ foundation plans

November 6, 2003

The government's controversial plans to create foundation hospitals have been rejected by the House of Lords.Peers singled out for particular …

NHS launches ‘one-stop’ website

November 6, 2003

A new one-stop NHS website portal for the public and patients has been officially launched by the government.The site has …

Supplementary prescribing

November 6, 2003
NHS, healthcare, pharmacist, supplementary prescribing

Supplementary prescribing by pharmacists will soon become a reality. The first wave of pharmacy supplementary prescribers begin their courses this …

Foundation distrust

November 6, 2003
NHS, foundation hospitals, healthcare

Despite fierce opposition from several areas, foundation hospitals look set to become a reality in 2004. But what will they …

Teva stretches lead in generics

November 5, 2003
Sales and Marketing

Teva has agreed to acquire US generics company Sicor for $3.4 billion and increased its third quarter profits 63%, led …

Lilly resolves FDA manufacturing dispute

November 5, 2003
Manufacturing and Production

Two Eli Lilly manufacturing sites have passed FDA inspections resolving a long-running dispute and paving the way for the launch …

Making the switch

November 5, 2003
Sales and Marketing P, POM, switch

Switching is not a given and a successful POM to P transition requires considerable research and planning to extend unique …

HRT – Too great a risk ?

November 4, 2003
Research and Development HRT, clinical trial

The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …

The Gateway to Local Adoption Series

Latest content